{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T20:11:06Z","timestamp":1793045466576,"version":"4.5.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T00:00:00Z","timestamp":1758758400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T00:00:00Z","timestamp":1758758400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"JSPS KAKENHI","award":["22K08011"],"award-info":[{"award-number":["22K08011"]}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP21fk0210090"],"award-info":[{"award-number":["JP21fk0210090"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-17560-7","type":"journal-article","created":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T13:46:14Z","timestamp":1758807974000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Conjugated bile acids in serum reflect disease severity and predict survival in chronic liver disease of humans and rats"],"prefix":"10.1038","volume":"15","author":[{"given":"Akiko","family":"Eguchi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Motoh","family":"Iwasa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teruo","family":"Miyazaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mina","family":"Tempaku","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masako","family":"Ichishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuyuki","family":"Tamai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryuta","family":"Shigefuku","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshinao","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Honda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masatoshi","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadashi","family":"Ikegami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hayato","family":"Nakagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,25]]},"reference":[{"key":"17560_CR1","doi-asserted-by":"publisher","DOI":"10.1111\/hepr.14059","author":"K Tajima","year":"2024","unstructured":"Tajima, K. et al. Total bile acids levels as a stratification tool for screening portopulmonary hypertension in patients with decompensated cirrhosis. Hepatol. Res. Off. J. Jpn. Soc. Hepatol. https:\/\/doi.org\/10.1111\/hepr.14059 (2024).","journal-title":"Hepatol. Res. Off. J. Jpn. Soc. Hepatol."},{"key":"17560_CR2","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.ajpath.2010.11.026","volume":"178","author":"K Allen","year":"2011","unstructured":"Allen, K., Jaeschke, H. & Copple, B. L. Bile acids induce inflammatory genes in hepatocytes: A novel mechanism of inflammation during obstructive cholestasis. Am. J. Pathol. 178, 175\u2013186. https:\/\/doi.org\/10.1016\/j.ajpath.2010.11.026 (2011).","journal-title":"Am. J. Pathol."},{"key":"17560_CR3","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1111\/liv.13201","volume":"37","author":"T Horvatits","year":"2017","unstructured":"Horvatits, T. et al. Serum bile acids as marker for acute decompensation and acute-on-chronic liver failure in patients with non-cholestatic cirrhosis. Liver Int. Off. J. Int. Assoc. Study Liver 37, 224\u2013231. https:\/\/doi.org\/10.1111\/liv.13201 (2017).","journal-title":"Liver Int. Off. J. Int. Assoc. Study Liver"},{"key":"17560_CR4","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/0378-4274(92)90156-e","volume":"61","author":"NM Delzenne","year":"1992","unstructured":"Delzenne, N. M., Calderon, P. B., Taper, H. S. & Roberfroid, M. B. Comparative hepatotoxicity of cholic acid, deoxycholic acid and lithocholic acid in the rat: In vivo and in vitro studies. Toxicol. Lett. 61, 291\u2013304. https:\/\/doi.org\/10.1016\/0378-4274(92)90156-e (1992).","journal-title":"Toxicol. Lett."},{"key":"17560_CR5","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1146\/annurev.biochem.72.121801.161712","volume":"72","author":"DW Russell","year":"2003","unstructured":"Russell, D. W. The enzymes, regulation, and genetics of bile acid synthesis. Annu. Rev. Biochem. 72, 137\u2013174. https:\/\/doi.org\/10.1146\/annurev.biochem.72.121801.161712 (2003).","journal-title":"Annu. Rev. Biochem."},{"key":"17560_CR6","doi-asserted-by":"publisher","first-page":"3796","DOI":"10.1038\/s41467-024-47897-y","volume":"15","author":"T Chen","year":"2024","unstructured":"Chen, T. et al. Metabolic phenotyping reveals an emerging role of ammonia abnormality in Alzheimer\u2019s disease. Nat. Commun. 15, 3796. https:\/\/doi.org\/10.1038\/s41467-024-47897-y (2024).","journal-title":"Nat. Commun."},{"key":"17560_CR7","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1002\/jcsm.12798","volume":"12","author":"L Feng","year":"2021","unstructured":"Feng, L. et al. Bile acid metabolism dysregulation associates with cancer cachexia: Roles of liver and gut microbiome. J. Cachexia Sarcopenia Muscle 12, 1553\u20131569. https:\/\/doi.org\/10.1002\/jcsm.12798 (2021).","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"17560_CR8","doi-asserted-by":"publisher","first-page":"103290","DOI":"10.1016\/j.ebiom.2021.103290","volume":"66","author":"G Xie","year":"2021","unstructured":"Xie, G. et al. Conjugated secondary 12alpha-hydroxylated bile acids promote liver fibrogenesis. EBioMedicine 66, 103290. https:\/\/doi.org\/10.1016\/j.ebiom.2021.103290 (2021).","journal-title":"EBioMedicine"},{"key":"17560_CR9","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1111\/apt.17533","volume":"58","author":"S Wiese","year":"2023","unstructured":"Wiese, S. et al. Altered serum bile acid composition is associated with cardiac dysfunction in cirrhosis. Aliment. Pharmacol. Ther. 58, 453\u2013462. https:\/\/doi.org\/10.1111\/apt.17533 (2023).","journal-title":"Aliment. Pharmacol. Ther."},{"key":"17560_CR10","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1002\/hep.29359","volume":"67","author":"P Puri","year":"2018","unstructured":"Puri, P. et al. The presence and severity of nonalcoholic steatohepatitis is associated with specific changes in circulating bile acids. Hepatology 67, 534\u2013548. https:\/\/doi.org\/10.1002\/hep.29359 (2018).","journal-title":"Hepatology"},{"key":"17560_CR11","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/j.jhep.2018.03.031","volume":"69","author":"K Brandl","year":"2018","unstructured":"Brandl, K. et al. Dysregulation of serum bile acids and FGF19 in alcoholic hepatitis. J. Hepatol. 69, 396\u2013405. https:\/\/doi.org\/10.1016\/j.jhep.2018.03.031 (2018).","journal-title":"J. Hepatol."},{"key":"17560_CR12","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1194\/jlr.M072819","volume":"58","author":"A Wahlstrom","year":"2017","unstructured":"Wahlstrom, A. et al. Induction of farnesoid X receptor signaling in germ-free mice colonized with a human microbiota. J. Lipid Res. 58, 412\u2013419. https:\/\/doi.org\/10.1194\/jlr.M072819 (2017).","journal-title":"J. Lipid Res."},{"key":"17560_CR13","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24054258","author":"L Xing","year":"2023","unstructured":"Xing, L. et al. A dual coverage monitoring of the bile acids profile in the liver-gut axis throughout the whole inflammation-cancer transformation progressive: Reveal hepatocellular carcinoma pathogenesis. Int. J. Mol. Sci. https:\/\/doi.org\/10.3390\/ijms24054258 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"17560_CR14","doi-asserted-by":"publisher","first-page":"e00131","DOI":"10.14309\/ctg.0000000000000131","volume":"11","author":"S Sydor","year":"2020","unstructured":"Sydor, S. et al. Altered microbiota diversity and bile acid signaling in cirrhotic and noncirrhotic NASH-HCC. Clin. Transl. Gastroenterol. 11, e00131. https:\/\/doi.org\/10.14309\/ctg.0000000000000131 (2020).","journal-title":"Clin. Transl. Gastroenterol."},{"key":"17560_CR15","doi-asserted-by":"publisher","first-page":"2743","DOI":"10.1002\/ijc.33051","volume":"147","author":"JL Petrick","year":"2020","unstructured":"Petrick, J. L. et al. Prediagnostic concentrations of circulating bile acids and hepatocellular carcinoma risk: REVEAL-HBV and HCV studies. Int. J. Cancer 147, 2743\u20132753. https:\/\/doi.org\/10.1002\/ijc.33051 (2020).","journal-title":"Int. J. Cancer"},{"key":"17560_CR16","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.ebiom.2018.10.030","volume":"37","author":"G Xie","year":"2018","unstructured":"Xie, G. et al. Dysregulated bile acid signaling contributes to the neurological impairment in murine models of acute and chronic liver failure. EBioMedicine 37, 294\u2013306. https:\/\/doi.org\/10.1016\/j.ebiom.2018.10.030 (2018).","journal-title":"EBioMedicine"},{"key":"17560_CR17","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1016\/j.jcmgh.2021.04.013","volume":"12","author":"DJ Matye","year":"2021","unstructured":"Matye, D. J. et al. Combined ASBT inhibitor and FGF15 treatment improves therapeutic efficacy in experimental nonalcoholic steatohepatitis. Cell. Mol. Gastroenterol. Hepatol. 12, 1001\u20131019. https:\/\/doi.org\/10.1016\/j.jcmgh.2021.04.013 (2021).","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"key":"17560_CR18","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1097\/HEP.0000000000000376","volume":"78","author":"FJ Caballero-Camino","year":"2023","unstructured":"Caballero-Camino, F. J. et al. A3907, a systemic ASBT inhibitor, improves cholestasis in mice by multiorgan activity and shows translational relevance to humans. Hepatology 78, 709\u2013726. https:\/\/doi.org\/10.1097\/HEP.0000000000000376 (2023).","journal-title":"Hepatology"},{"key":"17560_CR19","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1136\/gutjnl-2020-323345","volume":"71","author":"A Salhab","year":"2022","unstructured":"Salhab, A., Amer, J., Lu, Y. & Safadi, R. Sodium(+)\/taurocholate cotransporting polypeptide as target therapy for liver fibrosis. Gut 71, 1373\u20131385. https:\/\/doi.org\/10.1136\/gutjnl-2020-323345 (2022).","journal-title":"Gut"},{"key":"17560_CR20","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s12016-019-08731-2","volume":"58","author":"W Chen","year":"2020","unstructured":"Chen, W. et al. Comprehensive analysis of serum and fecal bile acid profiles and interaction with gut microbiota in primary biliary cholangitis. Clin. Rev. Allergy Immunol. 58, 25\u201338. https:\/\/doi.org\/10.1007\/s12016-019-08731-2 (2020).","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"17560_CR21","doi-asserted-by":"publisher","first-page":"19375","DOI":"10.1016\/S0021-9258(17)32178-6","volume":"269","author":"CN Falany","year":"1994","unstructured":"Falany, C. N., Johnson, M. R., Barnes, S. & Diasio, R. B. Glycine and taurine conjugation of bile acids by a single enzyme. Molecular cloning and expression of human liver bile acid CoA: Amino acid n-acyltransferase. J. Biol. Chem. 269, 19375\u201319379 (1994).","journal-title":"J. Biol. Chem."},{"key":"17560_CR22","doi-asserted-by":"publisher","first-page":"2765","DOI":"10.1002\/hep4.2041","volume":"6","author":"BD Alrehaili","year":"2022","unstructured":"Alrehaili, B. D. et al. Bile acid conjugation deficiency causes hypercholanemia, hyperphagia, islet dysfunction, and gut dysbiosis in mice. Hepatol. Commun. 6, 2765\u20132780. https:\/\/doi.org\/10.1002\/hep4.2041 (2022).","journal-title":"Hepatol. Commun."},{"key":"17560_CR23","doi-asserted-by":"publisher","first-page":"G88","DOI":"10.1152\/ajpgi.00450.2004","volume":"289","author":"C Rust","year":"2005","unstructured":"Rust, C., Bauchmuller, K., Fickert, P., Fuchsbichler, A. & Beuers, U. Phosphatidylinositol 3-kinase-dependent signaling modulates taurochenodeoxycholic acid-induced liver injury and cholestasis in perfused rat livers. Am. J. Physiol. Gastrointest. Liver Physiol. 289, G88-94. https:\/\/doi.org\/10.1152\/ajpgi.00450.2004 (2005).","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"17560_CR24","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1002\/hep4.1322","volume":"3","author":"Z Yang","year":"2019","unstructured":"Yang, Z. et al. Serum metabolomic profiling identifies key metabolic signatures associated with pathogenesis of alcoholic liver disease in humans. Hepatol. Commun. 3, 542\u2013557. https:\/\/doi.org\/10.1002\/hep4.1322 (2019).","journal-title":"Hepatol. Commun."},{"key":"17560_CR25","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1111\/liv.15481","volume":"43","author":"K Zizalova","year":"2023","unstructured":"Zizalova, K. et al. Serum concentration of taurochenodeoxycholic acid predicts clinically significant portal hypertension. Liver Int. Off. J. Int. Assoc. Study Liver 43, 888\u2013895. https:\/\/doi.org\/10.1111\/liv.15481 (2023).","journal-title":"Liver Int. Off. J. Int. Assoc. Study Liver"},{"key":"17560_CR26","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1007\/s12072-023-10610-0","volume":"18","author":"S Feng","year":"2024","unstructured":"Feng, S. et al. Bile acids induce liver fibrosis through the NLRP3 inflammasome pathway and the mechanism of FXR inhibition of NLRP3 activation. Hepatol. Int. 18, 1040\u20131052. https:\/\/doi.org\/10.1007\/s12072-023-10610-0 (2024).","journal-title":"Hepatol. Int."},{"key":"17560_CR27","doi-asserted-by":"publisher","DOI":"10.1097\/HC9.0000000000000478","author":"RO Ali","year":"2024","unstructured":"Ali, R. O. et al. Taurine-conjugated bile acids and their link to hepatic S1PR2 play a significant role in hepatitis C-related liver disease. Hepatol. Commun. https:\/\/doi.org\/10.1097\/HC9.0000000000000478 (2024).","journal-title":"Hepatol. Commun."},{"key":"17560_CR28","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1111\/j.1440-1746.2006.04363.x","volume":"21","author":"F Hirano","year":"2006","unstructured":"Hirano, F., Haneda, M. & Makino, I. Chenodeoxycholic acid and taurochenodexycholic acid induce anti-apoptotic cIAP-1 expression in human hepatocytes. J. Gastroenterol. Hepatol. 21, 1807\u20131813. https:\/\/doi.org\/10.1111\/j.1440-1746.2006.04363.x (2006).","journal-title":"J. Gastroenterol. Hepatol."},{"key":"17560_CR29","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.80638","author":"Y Tamai","year":"2022","unstructured":"Tamai, Y. et al. Association of lithocholic acid with skeletal muscle hypertrophy through TGR5-IGF-1 and skeletal muscle mass in cultured mouse myotubes, chronic liver disease rats and humans. eLife https:\/\/doi.org\/10.7554\/eLife.80638 (2022).","journal-title":"Elife"},{"key":"17560_CR30","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1111\/hepr.13411","volume":"49","author":"N Kokudo","year":"2019","unstructured":"Kokudo, N. et al. Clinical practice guidelines for hepatocellular carcinoma: The Japan society of hepatology 2017 (4th JSH-HCC guidelines) 2019 update. Hepatol. Res. Off. J. Jpn. Soc. Hepatol. 49, 1109\u20131113. https:\/\/doi.org\/10.1111\/hepr.13411 (2019).","journal-title":"Hepatol. Res. Off. J. Jpn. Soc. Hepatol."},{"key":"17560_CR31","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1200\/JCO.2014.57.9151","volume":"33","author":"PJ Johnson","year":"2015","unstructured":"Johnson, P. J. et al. Assessment of liver function in patients with hepatocellular carcinoma: A new evidence-based approach-the ALBI grade. J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol. 33, 550\u2013558. https:\/\/doi.org\/10.1200\/JCO.2014.57.9151 (2015).","journal-title":"J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol."},{"key":"17560_CR32","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1002\/hep.21178","volume":"43","author":"RK Sterling","year":"2006","unstructured":"Sterling, R. K. et al. Development of a simple noninvasive index to predict significant fibrosis in patients with HIV\/HCV coinfection. Hepatology 43, 1317\u20131325. https:\/\/doi.org\/10.1002\/hep.21178 (2006).","journal-title":"Hepatology"},{"key":"17560_CR33","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1016\/j.jpba.2005.09.013","volume":"40","author":"M Ando","year":"2006","unstructured":"Ando, M. et al. High sensitive analysis of rat serum bile acids by liquid chromatography\/electrospray ionization tandem mass spectrometry. J. Pharm. Biomed. Anal. 40, 1179\u20131186. https:\/\/doi.org\/10.1016\/j.jpba.2005.09.013 (2006).","journal-title":"J. Pharm. Biomed. Anal."},{"key":"17560_CR34","doi-asserted-by":"publisher","first-page":"111181","DOI":"10.1016\/j.biopha.2020.111181","volume":"135","author":"Y Tamai","year":"2021","unstructured":"Tamai, Y. et al. Branched-chain amino acids and l-carnitine attenuate lipotoxic hepatocellular damage in rat cirrhotic liver. Biomed. Pharmacother. 135, 111181. https:\/\/doi.org\/10.1016\/j.biopha.2020.111181 (2021).","journal-title":"Biomed. Pharmacother."},{"key":"17560_CR35","doi-asserted-by":"publisher","first-page":"e70309","DOI":"10.1371\/journal.pone.0070309","volume":"8","author":"M Iwasa","year":"2013","unstructured":"Iwasa, M. et al. Branched-chain amino acid supplementation reduces oxidative stress and prolongs survival in rats with advanced liver cirrhosis. PLoS One 8, e70309. https:\/\/doi.org\/10.1371\/journal.pone.0070309 (2013).","journal-title":"PLoS One"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-17560-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-17560-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-17560-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T13:46:15Z","timestamp":1758807975000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-17560-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,25]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["17560"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-17560-7","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,25]]},"assertion":[{"value":"2 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"H2019-063.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Opt out.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"HKD43046","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and animal resource"}}],"article-number":"32911"}}